
Microdosing Psilocybin: What the Research Actually Shows
The two main microdosing protocols, what clinical studies found (including the null results), who it might help, and how to do it safely. Based on peer-reviewed research, not hype.
shroomDOSAGE Research Desk
We go through the peer-reviewed clinical literature — dosage trials, tryptamine assays, pharmacology studies — and translate the findings into language that actually makes sense.
Every claim cites a primary source. No jargon, no mysticism. Nothing here is medical advice.

The two main microdosing protocols, what clinical studies found (including the null results), who it might help, and how to do it safely. Based on peer-reviewed research, not hype.

SSRIs, MAOIs, lithium, and tramadol all interact with psilocybin — some reduce the effect, some create genuine danger. Here's what the clinical literature shows, in plain English.

Why psilocybin tolerance builds within hours of a single dose, why re-dosing the same day almost never works, and what the pharmacology says about the two-week reset timeline.

Tracking psilocybin sessions reveals patterns no single trip can show. Dose, strain, set, and setting — here's what your own session logs will teach you.

Research-grounded psilocybin dosage tiers by strain potency, body weight, and experience level — and how to use the shroomDOSAGE calculator.

A clear-eyed look at the psilocybin clinical trial landscape — what studies have been done, what they found, and what researchers say remains unknown.
Your cart is empty.
Browse the catalogue to add items.